FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2085102516> ?p ?o ?g. }

• W2085102516 endingPage "958" @default.
• W2085102516 startingPage "950" @default.
• W2085102516 abstract "Clinical evidence suggests that after initiation of dopaminergic medications some patients with Parkinson's disease (PD) develop psychotic symptoms, such as hallucinations and delusions. Here, we tested the hypothesis that the neurocognitive basis of this phenomenon can be defined as the formation of arbitrary and illusory associations between conditioned stimuli and reward signals, called aberrant salience. Young, never-medicated PD patients and matched controls were assessed on a speeded reaction time task in which the probe stimulus was preceded by conditioned stimuli that could signal monetary reward by color or shape. The patients and controls were re-evaluated after 12 weeks during which the patients received a dopamine agonist (pramipexole or ropinirole). Results indicated that dopamine agonists increased both adaptive and aberrant salience in PD patients, that is, formation of real and illusory associations between conditioned stimuli and reward, respectively. This effect was present when associations were assessed by means of faster responding after conditioned stimuli signaling reward (implicit salience) and overt rating of stimulus-reward links (explicit salience). However, unusual feelings and experiences, which are subclinical manifestations of psychotic-like symptoms, were specifically related to irrelevant and illusory stimulus-reward associations (aberrant salience) in PD patients receiving dopamine agonists. The learning of relevant and real stimulus-reward associations (adaptive salience) was not related to unusual experiences. These results suggest that dopamine agonists may increase psychotic-like experiences in young patients with PD, possibly by facilitating dopaminergic transmission in the ventral striatum, which results in aberrant associations between conditioned stimuli and reward." @default.
• W2085102516 created "2016-06-24" @default.
• W2085102516 creator A5021147267 @default.
• W2085102516 creator A5026179396 @default.
• W2085102516 creator A5048780563 @default.
• W2085102516 creator A5061964663 @default.
• W2085102516 creator A5067613564 @default.
• W2085102516 creator A5073629455 @default.
• W2085102516 date "2011-11-16" @default.
• W2085102516 modified "2023-10-16" @default.
• W2085102516 title "The Effect of Dopamine Agonists on Adaptive and Aberrant Salience in Parkinson's Disease" @default.
• W2085102516 cites W1738657257 @default.
• W2085102516 cites W1932237603 @default.
• W2085102516 cites W1967763879 @default.
• W2085102516 cites W1981955730 @default.
• W2085102516 cites W1983297775 @default.
• W2085102516 cites W1989178332 @default.
• W2085102516 cites W1997630930 @default.
• W2085102516 cites W2003244414 @default.
• W2085102516 cites W2008560062 @default.
• W2085102516 cites W2018759523 @default.
• W2085102516 cites W2020996348 @default.
• W2085102516 cites W2021831574 @default.
• W2085102516 cites W2024134876 @default.
• W2085102516 cites W2026692095 @default.
• W2085102516 cites W2039481622 @default.
• W2085102516 cites W2046713808 @default.
• W2085102516 cites W2053350293 @default.
• W2085102516 cites W2053535990 @default.
• W2085102516 cites W2058279623 @default.
• W2085102516 cites W2059614355 @default.
• W2085102516 cites W2064996887 @default.
• W2085102516 cites W2071120614 @default.
• W2085102516 cites W2083323215 @default.
• W2085102516 cites W2084606218 @default.
• W2085102516 cites W2088035273 @default.
• W2085102516 cites W2091469126 @default.
• W2085102516 cites W2095715008 @default.
• W2085102516 cites W2096193724 @default.
• W2085102516 cites W2096556047 @default.
• W2085102516 cites W2099910246 @default.
• W2085102516 cites W2100040139 @default.
• W2085102516 cites W2103733250 @default.
• W2085102516 cites W2103768739 @default.
• W2085102516 cites W2104774257 @default.
• W2085102516 cites W2104979561 @default.
• W2085102516 cites W2106064692 @default.
• W2085102516 cites W2126299515 @default.
• W2085102516 cites W2127432991 @default.
• W2085102516 cites W2139759905 @default.
• W2085102516 cites W2142830713 @default.
• W2085102516 cites W2144623340 @default.
• W2085102516 cites W2147639837 @default.
• W2085102516 cites W2155015170 @default.
• W2085102516 cites W2158819247 @default.
• W2085102516 cites W2160695817 @default.
• W2085102516 cites W2163647009 @default.
• W2085102516 cites W2163805252 @default.
• W2085102516 cites W2167659819 @default.
• W2085102516 cites W2167701625 @default.
• W2085102516 cites W2168122820 @default.
• W2085102516 cites W2170735591 @default.
• W2085102516 cites W2336893408 @default.
• W2085102516 cites W4231936410 @default.
• W2085102516 doi "https://doi.org/10.1038/npp.2011.278" @default.
• W2085102516 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3280658" @default.
• W2085102516 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22089321" @default.
• W2085102516 hasPublicationYear "2011" @default.
• W2085102516 type Work @default.
• W2085102516 sameAs 2085102516 @default.
• W2085102516 citedByCount "40" @default.
• W2085102516 countsByYear W20851025162012 @default.
• W2085102516 countsByYear W20851025162013 @default.
• W2085102516 countsByYear W20851025162014 @default.
• W2085102516 countsByYear W20851025162015 @default.
• W2085102516 countsByYear W20851025162016 @default.
• W2085102516 countsByYear W20851025162017 @default.
• W2085102516 countsByYear W20851025162018 @default.
• W2085102516 countsByYear W20851025162019 @default.
• W2085102516 countsByYear W20851025162020 @default.
• W2085102516 countsByYear W20851025162021 @default.
• W2085102516 countsByYear W20851025162022 @default.
• W2085102516 countsByYear W20851025162023 @default.
• W2085102516 crossrefType "journal-article" @default.
• W2085102516 hasAuthorship W2085102516A5021147267 @default.
• W2085102516 hasAuthorship W2085102516A5026179396 @default.
• W2085102516 hasAuthorship W2085102516A5048780563 @default.
• W2085102516 hasAuthorship W2085102516A5061964663 @default.
• W2085102516 hasAuthorship W2085102516A5067613564 @default.
• W2085102516 hasAuthorship W2085102516A5073629455 @default.
• W2085102516 hasBestOaLocation W20851025161 @default.
• W2085102516 hasConcept C108154423 @default.
• W2085102516 hasConcept C126322002 @default.
• W2085102516 hasConcept C137183658 @default.
• W2085102516 hasConcept C138496976 @default.
• W2085102516 hasConcept C15744967 @default.
• W2085102516 hasConcept C169760540 @default.
• W2085102516 hasConcept C180747234 @default.

• next